Provides Lenses Up to Eight Hours of Moisture*

VAUGHAN, ON , Dec. 13, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better in order to live better, today announced that it has received 510(k) clearance from the U. S. Food and Drug Administration (FDA) with regard to Biotrue Hydration Boost Contact Lens Rehydrating drops, a preservative-free multi-dose rehydrating drop for use with soft and rigid gas permeable contact lenses.  

“We are proud to continue to build upon our successful Biotrue brand with the FDA clearance of Biotrue Hydration Boost for Contacts, ” said Joe Gordon , president, Global Consumer, Vision Care and Surgical, Bausch + Lomb. “Approximately, one-third  of the 45 million contact lens wearers in  the  United States  experience contact lens dryness. 1-3 We look forward to making this product available during the first half of 2023 to provide lens wearers with the new lens drop that delivers instant moisture and provides up in order to eight hours of moisture. “*

Inspired by the biology of the eye, Biotrue Hydration Boost Get in touch with Lens drops contain a combination of ingredients informed by the particular Tear Film and Ocular Surface Society’s DEWS II report including hyaluronan, a moisturizer found naturally in the vision, and other naturally inspired ingredients. Biotrue Hydration Boost for Connections also matches the pH of healthy tears regarding comfort.

“Many of my patients experience dry, uncomfortable contact lenses throughout the day, ” stated Mile Brujic , O. D., Premier Vision Group,   Bowling Green, Ohio . “The availability of Biotrue  Hydration Increase for Contacts will help the patients quickly reduce their contact lens-related dryness. I anticipate recommending this product to patients as soon because it is available next year. ”

About Bausch + Lomb
Bausch + Lomb is devoted to protecting and enhancing the gift of sight for millions of people around the world – from the particular moment associated with birth through every phase of life. Its comprehensive portfolio of more than 400 products includes disposable lenses, lens care products, eye maintenance systems, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices plus instruments. Founded in 1853, Bausch + Lomb has a significant worldwide research and development, manufacturing and commercial footprint with more than 12, 000 employees and a presence inside nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey . For more information, visit  www.bausch.com   plus connect with us on Twitter , LinkedIn , Facebook and Instagram .

Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words “anticipates, inch “hopes, inches “expects, ” “intends, inch “plans, inches “should, ” “could, inch “would, inches “may, ” “believes, inch “estimates, inches “potential, ” “target, inch or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are usually subject to certain risks and uncertainties that will could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the particular risks plus uncertainties discussed in Bausch + Lomb’s filings with the U. H. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are usually not restricted to, risks plus uncertainties caused by or relating to the evolving COVID-19 pandemic, and the particular fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which might have the material adverse impact on Bausch + Lomb, including but not limited to its project development timelines, launches plus costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These types of forward-looking claims speak only as associated with the date hereof. Bausch + Lomb undertakes no obligation in order to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or even to reveal actual outcomes, unless required by law.

*Based on a laboratory study

References

  1. Multi-Sponsor Surveys Inc. The 2019 Study of the  U. T.   Customer Lens Market. January 2020 .
  2. American Optometric Association.   www.aoa.org .
  3. Centers intended for Disease Control and Prevention.   www.cdc.gov .

®/TM are usually   trademarks of Bausch & Lomb Incorporated or its affiliates.
Any other product/brand names and/or logos are trademarks from the respective owners.
© 2022 Bausch & Lomb Incorporated or even its affiliate marketers.
BRD. 0007. USA. 22

SOURCE Bausch + Lomb Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *